Revenue for China's Plastic Surgery Hospitals industry is expected to rise an annualized 14.6% over the five years through 2023. This trend includes anticipated revenue growth of 15.1% in the current year, to $40.6 billion. Rising plastic and cosmetic surgery demand has been driven by changing attitudes toward self-image, technological advancements in industry procedures, higher disposable incomes and China's ageing population. Plastic Surgery Hospitals in China perform surgical and non-surgical procedures intended to enhance an individual’s physical appearance for cosmetic or reconstructive purposes. Clinics which perform similar procedures are also included in the industry. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
ABOUT THIS INDUSTRY- Industry Definition
- Main Activities
- Similar Industries
- Additional Resources
- Executive Summary
- Key External Drivers
- Current Performance
- Industry Outlook
- Industry Life Cycle
- Supply Chain
- Products & Services
- Demand Determinants
- Major Markets
- International Trade
- Business Locations
- Market Share Concentration
- Key Success Factors
- Cost Structure Benchmarks
- Basis of Competition
- Barriers to Entry
- Industry Globalization
OPERATING CONDITIONS
- Capital Intensity
- Technology & Systems
- Revenue Volatility
- Regulation & Policy
- Industry Assistance
- Industry Data
- Annual Change
- Key Ratios
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Shanghai Ninth People's Hospital
- Peking Union Medical College Hospital
- Nanfang Hospital of Southern Medical University
- Plastic Surgery Hospital of Chinses Academy of Medical Science
- West China Hospital, Sichuan University
Methodology
LOADING...
